Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2003
06/19/2003US20030115617 Transgenic animal; antidiabetic agents, anxiolytic agents, analgesics, antiepileptic agents
06/19/2003US20030114658 Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
06/19/2003US20030114652 Hybrid polypeptide; genetic engineering
06/19/2003US20030114646 Human cystatin F
06/19/2003US20030114523 Cell having modified cell membrane
06/19/2003US20030114398 Monoclonal antiidiotype antibody 1A7 eliciting an anti-ganglioside GD2 response and overcomes immune tolerance; detecting an anti-GD2 antibody bound to a tumor cell; kits; melanoma, neuroblastoma, glioma, soft tissue sarcoma
06/19/2003US20030114382 Angiogenesis inhibition
06/19/2003US20030114381 Method of treating sensorineural hearing loss
06/19/2003US20030114330 BGL5 beta-glucosidase and nucleic acids encoding the same
06/19/2003US20030113920 Transducting, dividing cells; gene expression; gene therapy
06/19/2003US20030113918 Gene therapy; expression of polynucleotide in nucleic acids in dopaminergic cell; Parkinson's disease
06/19/2003US20030113917 Methods for delivering nucleic acid molecules into cells and assessment thereof
06/19/2003US20030113916 Simultaneous application of different ammonium to nitrate molar rations
06/19/2003US20030113915 Device and method for seed-train expansion of mammalian cells
06/19/2003US20030113913 Culture product; gene therapy; amplification; induction cell differentiation
06/19/2003US20030113912 Hematopoietic stem cell proliferating agents
06/19/2003US20030113910 Pluripotent stem cells derived without the use of embryos or fetal tissue
06/19/2003US20030113909 G protein coupled receptor protein, production and use thereof
06/19/2003US20030113901 Cell production
06/19/2003US20030113898 Methods for producing high titre vectors and compositions used in such methods
06/19/2003US20030113873 Screening modulators of G-protein coupled binding proteins; analgesics; muscle-relaxants; cognition activators; learning enhancement
06/19/2003US20030113870 Polypeptides homologous to VEGF and BMP1
06/19/2003US20030113869 Human FGF gene and gene expression products
06/19/2003US20030113868 Human metabotropic glutamate receptor subtype mGluR7b
06/19/2003US20030113867 Muscle receptor proteins; transport proteins; antitumor agents; antiinflammatory agents; antidiabetic agents; modulation of muscle contraction
06/19/2003US20030113864 Induction of chondrocyte proliferation/differentiation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
06/19/2003US20030113863 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113862 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113861 Induction of chondrocyte differentiation/proliferation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
06/19/2003US20030113859 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113858 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113857 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113856 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113855 Induction of chondrocyte proliferation/differentiation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
06/19/2003US20030113852 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113851 Induction of chondrocyte differentaition/proliferation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
06/19/2003US20030113849 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113848 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113844 Delayed rectifier potassium channel subunit
06/19/2003US20030113843 For stimulating release of tumor necrosis factor, and/or cell proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; antiinflammatory agents; anticarcingenic agents; antitumor agents; cancer diagnosis
06/19/2003US20030113842 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113838 Epidermal growth factor; antitumor agents; antiproliferative agents; antiinflammatory agents; mitogen-activated protein kinases
06/19/2003US20030113817 Hemogen-EDAG: novel nuclear factors expressed in hematopoietic development
06/19/2003US20030113813 Methods and devices for the integrated discovery of cell culture environments
06/19/2003US20030113812 Evaluating modulators of neuron propagation; bone morphogenetic proteins; epidermal growth factors; erythropoietins; pleiotrophins; hepatocyte growth factors; somatomedins; nerve growth factors; interleukins
06/19/2003US20030113811 Detecting membrane protein agonist/antagonist; alzheimer's diagnosis and treatment
06/19/2003US20030113795 Membrane protein; cytokines; antitumor agents; anticarcinogenic agents; antiinflammatory agents; cancer diagnosis
06/19/2003US20030113793 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113789 Protease peptides; anticarcinogenic agents; neurotransmitters; antidiabetic agents
06/19/2003US20030113772 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113771 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113764 Compositions and methods for the treatment of tumors
06/19/2003US20030113747 Genetically engineered adenosine triphosphate generating polypeptide; sequences determination; reporter molecules
06/19/2003US20030113743 Method for detection of micrometastatic prostate cancer
06/19/2003US20030113735 Glucanases/glucosidase/hydrolases; conversion of cellulose to sugars and/or ethanol; laundering detergents
06/19/2003US20030113734 EGVII endoglucanase and nucleic acids encoding the same
06/19/2003US20030113732 EGVI endoglucanase and nucleic acids encoding the same
06/19/2003US20030113719 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113718 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113709 Semiconductor nanocrystal-based cellular imaging
06/19/2003US20030113707 Erythrocyte transport protein suspension obtained by removing fibrin and separating erythrocytes from hematocrit; storage stability; antihypoxic agents
06/19/2003US20030113705 Inhibiting proteolytic enzymes in urine/blood samples by binding trace elements, reducing degradation of cell walls
06/19/2003US20030113341 Methods of using FLT3-ligand in the treatment of cancer
06/19/2003US20030113333 A kit containing a binding protein and a carrier molecule, binds with a hapten moiety and binds with a target antigen; monoclonal antibodies and engineered antibodies
06/19/2003US20030113305 Compositions and methods for treating diabetes
06/19/2003US20030113304 Selective tissue site revascularization by combined focal injury and hematopoietic stem cell introduction
06/19/2003US20030113303 Delivering a translocation stimulator to a target zone of the tissue, introducing human embryonic stem cells to the mammal for homing the human to the target zone of the tissue for effecting myogenesis at the target zone
06/19/2003US20030113302 Use of recipient endothelial cells for enhanced vascularization of tissue and tissue-engineered construct transplants
06/19/2003US20030113301 Muscle cells and their use in cardiac repair
06/19/2003US20030113300 Human glucose-dependent insulin-secreting cell line
06/19/2003US20030113296 A tissue-specific transcriptional regulatory sequence(promoter or enhancer) operably linked to the coding region of a gene that is essential of replication of the vector (DNA tumor viral vector)
06/19/2003US20030113295 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders
06/19/2003US20030113292 Interferon-gamma-inducing factor (IGIF/IL-18); promoting differentiation of CD4-lymphocytes
06/19/2003US20030111016 Methods for gamete production in birds
06/19/2003CA2848193A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
06/19/2003CA2784260A1 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003CA2692325A1 Islet cells from human embryonic stem cells
06/19/2003CA2472054A1 Compositions and methods for normalizing assays
06/19/2003CA2470853A1 Human cell culture medium and culture method
06/19/2003CA2469802A1 A structure for presenting desired peptide sequences
06/19/2003CA2469792A1 In vitro production of dendritic cells from cd14+ monocytes especially for the preparation of suspension, monolayer and three-dimensional cell and/or tissue models, and use of these models
06/19/2003CA2469589A1 Method of large scale production of hepatitis a virus
06/19/2003CA2469494A1 Novel chimeric tnf ligands
06/19/2003CA2469484A1 Method of isolation and purification of trypsin from pronase and use thereof
06/19/2003CA2469483A1 Hematopoietic cells from human embryonic stem cells
06/19/2003CA2469274A1 Tumor antigens
06/19/2003CA2469161A1 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003CA2469027A1 Human genes and gene expression products isolated from human prostate
06/19/2003CA2468753A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
06/19/2003CA2468335A1 Chondrocyte precursors derived from human embryonic stem cells
06/19/2003CA2467689A1 Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
06/19/2003CA2461491A1 Methods of screening for antagonists of apm1/gzip
06/18/2003EP1319715A1 IMP dehydrogenase and its use for the identification of fungicidal substances
06/18/2003EP1319709A1 Disruption of the glutathione S-transferase-omega-1 gene
06/18/2003EP1319708A2 Human recombinant cell for bone or cartilage cell binding
06/18/2003EP1319669A2 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
06/18/2003EP1319408A1 Remedies for heart failure
06/18/2003EP1319182A2 G-csf analog compositions and methods
06/18/2003EP1319079A1 Talaromyces xylanase